Publicaciones (54) Publicaciones de PABLO GUISADO VASCO

2024

  1. Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment

    Infectious Diseases, Vol. 56, Núm. 7, pp. 575-580

2023

  1. Erratum: Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019 (Journal of Infectious Diseases (2022) 226 (1, 1-5) DOI: 10.1093/jid/jiac090)

    Journal of Infectious Diseases

  2. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

  3. Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19

    International Journal of Infectious Diseases, Vol. 135, pp. 12-17

  4. Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  5. Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

    Journal of Clinical Medicine, Vol. 12, Núm. 3

2022

  1. Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019

    The Journal of infectious diseases, Vol. 226, Núm. 1, pp. 1-5

  2. Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia

    Journal of Hematology and Oncology

  3. Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

    Life science alliance, Vol. 5, Núm. 4

  4. Remdesivir in Very Old Patients (≥80 Years) Hospitalized with COVID-19: Real World Data from the SEMI-COVID-19 Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 13

2021

  1. Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain

    The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 76, Núm. 3, pp. e28-e37

  2. Cyclosporine A and COVID19 – The COQUIMA cohort – Author's reply

    EClinicalMedicine

  3. Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and hemodialysis

    Nefrologia, Vol. 41, Núm. 2, pp. 174-181

  4. Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy

    Annals of Oncology

  5. SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients

    Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957

2020

  1. COVID-19 and Metabolic Syndrome: NF-κB Activation. Crossroads

    Trends in Endocrinology and Metabolism

  2. Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)

    EClinicalMedicine, Vol. 28

  3. Treatment-induced diabetes neuropathy: Description of singular clinical signs to reach a prompt diagnosis

    BMJ Case Reports, Vol. 13, Núm. 12

2019

  1. Commentary on "evaluation of Patients for Zika Virus Infection in a Travel Clinic in the Southeast United States, 2016"

    Southern Medical Journal

  2. Coronary artery calcification in patients with diabetes mellitus and advanced chronic kidney disease

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 5, pp. 297-304